Figure 3
Trends with dose in relative risk (and 90% CI) for mortality from all malignant neoplasms excluding leukaemia, lung and pleural cancer.
Figure 3 | British Journal of Cancer
Trends with dose in relative risk (and 90% CI) for mortality from all malignant neoplasms excluding leukaemia, lung and pleural cancer.
